ATROPINE

N/A

Manufactured by Meridian Medical Technologies LLC

16,519 FDA adverse event reports analyzed

Last updated: 2026-04-14

About ATROPINE

ATROPINE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Meridian Medical Technologies LLC. The most commonly reported adverse reactions for ATROPINE include DRUG INEFFECTIVE, OFF LABEL USE, DIARRHOEA, HYPOTENSION, NAUSEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for ATROPINE.

Top Adverse Reactions

DRUG INEFFECTIVE610 reports
OFF LABEL USE555 reports
DIARRHOEA535 reports
HYPOTENSION487 reports
NAUSEA457 reports
DEATH446 reports
DYSPNOEA395 reports
FATIGUE383 reports
BRADYCARDIA380 reports
VOMITING363 reports
PAIN341 reports
CARDIAC ARREST308 reports
TOXICITY TO VARIOUS AGENTS289 reports
PYREXIA287 reports
HYPERTENSION251 reports
DRUG INTERACTION246 reports
FALL240 reports
HEADACHE237 reports
TACHYCARDIA231 reports
CONSTIPATION228 reports
ASTHENIA226 reports
ABDOMINAL PAIN204 reports
PNEUMONIA200 reports
RENAL FAILURE182 reports
FEBRILE NEUTROPENIA178 reports
CONDITION AGGRAVATED171 reports
NEUTROPENIA170 reports
DIZZINESS169 reports
MALAISE169 reports
OVERDOSE166 reports
ANXIETY165 reports
SOMNOLENCE164 reports
ACUTE KIDNEY INJURY163 reports
DECREASED APPETITE162 reports
ANAEMIA160 reports
DISEASE PROGRESSION153 reports
ERYTHEMA150 reports
RESPIRATORY FAILURE150 reports
CONFUSIONAL STATE146 reports
WEIGHT DECREASED142 reports
HYPERHIDROSIS138 reports
DEHYDRATION137 reports
THROMBOCYTOPENIA134 reports
CHEST PAIN132 reports
RASH130 reports
ATRIAL FIBRILLATION129 reports
DYSARTHRIA121 reports
NEUROPATHY PERIPHERAL121 reports
SEIZURE120 reports
ARTHRALGIA118 reports
PRODUCT USE IN UNAPPROVED INDICATION118 reports
COUGH112 reports
GENERAL PHYSICAL HEALTH DETERIORATION110 reports
DEPRESSED LEVEL OF CONSCIOUSNESS106 reports
PULMONARY EMBOLISM106 reports
CARDIO RESPIRATORY ARREST105 reports
PRURITUS105 reports
TREMOR105 reports
COMA104 reports
SEDATION103 reports
MUSCULAR WEAKNESS102 reports
GAIT DISTURBANCE100 reports
CARDIOGENIC SHOCK99 reports
RHABDOMYOLYSIS99 reports
BALANCE DISORDER98 reports
SEPSIS98 reports
STRESS CARDIOMYOPATHY98 reports
VENTRICULAR TACHYCARDIA98 reports
PAIN IN EXTREMITY97 reports
AGITATION95 reports
LOSS OF CONSCIOUSNESS94 reports
MOBILITY DECREASED92 reports
OEDEMA PERIPHERAL91 reports
OXYGEN SATURATION DECREASED91 reports
PULMONARY OEDEMA91 reports
ANAPHYLACTIC REACTION90 reports
URINARY TRACT INFECTION90 reports
BACK PAIN89 reports
DEPRESSION87 reports
HEART RATE INCREASED86 reports
ORTHOSTATIC HYPOTENSION86 reports
VENTRICULAR FIBRILLATION85 reports
INJURY84 reports
ALOPECIA83 reports
CHRONIC KIDNEY DISEASE83 reports
BLOOD PRESSURE INCREASED82 reports
INSOMNIA82 reports
METABOLIC ACIDOSIS82 reports
PARAESTHESIA82 reports
VISION BLURRED82 reports
DYSPHAGIA81 reports
PLEURAL EFFUSION81 reports
RENAL FAILURE ACUTE81 reports
BLOOD PRESSURE DECREASED79 reports
MYOCARDIAL INFARCTION79 reports
HAEMOGLOBIN DECREASED78 reports
INFUSION RELATED REACTION78 reports
INTENTIONAL OVERDOSE78 reports
VISUAL IMPAIRMENT78 reports
CARDIAC FAILURE CONGESTIVE77 reports

Report Outcomes

Out of 7,884 classified reports for ATROPINE:

Serious 91.9%Non-Serious 8.1%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male3,491 (50.1%)
Female3,415 (49.0%)
Unknown58 (0.8%)

Reports by Age

Age 67137 reports
Age 71137 reports
Age 77136 reports
Age 72135 reports
Age 58132 reports
Age 69132 reports
Age 64126 reports
Age 62125 reports
Age 68125 reports
Age 65121 reports
Age 70120 reports
Age 61112 reports
Age 57111 reports
Age 56110 reports
Age 63110 reports
Age 54109 reports
Age 66105 reports
Age 7599 reports
Age 5398 reports
Age 7397 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with ATROPINE?

This profile reflects 16,519 FDA FAERS reports that mention ATROPINE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for ATROPINE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, OFF LABEL USE, DIARRHOEA, HYPOTENSION, NAUSEA, DEATH. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures ATROPINE?

Labeling and FAERS entries often list Meridian Medical Technologies LLC in connection with ATROPINE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.